Related Experiment Video
Updated: Jun 4, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer
Jun Hao1, Shuyu Zhang, Yingqi Zhou
1Department of Pancreatic Surgery, Changhai Hospital, Second Military Medical University, Shanghai 200433, China.
Abstract:
MicroRNAs (miRNAs) have emerged as important regulators in the development of pancreatic cancer and may be a valuable therapeutic application. DPC4/Smad4 is a critical tumor suppressor involved in the progression of pancreatic cancer, but few studies have been conducted to determine its relationship with miRNAs. In this study, we identify miR-421 as a potential regulator of DPC4/Smad4. We find that in human clinical specimens of pancreatic cancer miR-421 is aberrantly upregulated while DPC4/Smad4 is strongly repressed, and their levels of expression are inversely correlated. Moreover, ectopic expression of miR-421 significantly decreases DPC4/Smad4 protein level in pancreatic cancer cell lines and simultaneously promotes cell proliferation and colony formation in vitro. Our findings identify miR-421 as a potent regulator of DPC4/Smad4, which may provide a novel therapeutic strategy for treatment of DPC4/Smad4-driven pancreatic cancer.
Insights
MicroRNAs (miRNAs) regulate pancreatic cancer. This study found miR-421 upregulates in pancreatic tumors, suppressing DPC4/Smad4 and promoting cancer growth, suggesting a new therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are key regulators in pancreatic cancer development.
- DPC4/Smad4 is a crucial tumor suppressor in pancreatic cancer progression.
- The relationship between DPC4/Smad4 and miRNAs is not well-understood.
Purpose of the Study:
- To identify miRNAs that regulate DPC4/Smad4 in pancreatic cancer.
- To investigate the functional role of miR-421 in pancreatic cancer progression.
Main Methods:
- Analysis of miRNA and DPC4/Smad4 expression in human pancreatic cancer specimens.
- Ectopic expression of miR-421 in pancreatic cancer cell lines.
- Assessment of cell proliferation and colony formation assays in vitro.
Main Results:
- miR-421 was found to be aberrantly upregulated in pancreatic cancer tissues.
- DPC4/Smad4 expression was inversely correlated with miR-421 levels.
- Ectopic miR-421 expression reduced DPC4/Smad4 protein levels and enhanced cell proliferation and colony formation.
Conclusions:
- miR-421 is identified as a potent regulator of DPC4/Smad4 in pancreatic cancer.
- This regulatory relationship offers a potential novel therapeutic strategy for DPC4/Smad4-driven pancreatic cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Experimental RNAi

